| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/09/2003 | US6617309 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 09/09/2003 | US6617307 Useful for treatment of fractures, as a filler in deficient sites of bone, for inhibition of decrease in bone substance related to osteoporosis and periodontic diseases |
| 09/09/2003 | US6617306 Therapeutic agent is conjugated to the carrier via a biodegradable disulfide bond. |
| 09/09/2003 | US6617171 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect |
| 09/09/2003 | US6617162 Antisense modulation of estrogen receptor alpha expression |
| 09/09/2003 | US6617160 From mouse immunoglobulin, which inhibits binding of VEGF (vascular endothelial growth factor) to its receptor; use in diagnosis and treatment of solid tumors, cancer, rheumatoid arthritis, diabetic retinopathy and psoriasis |
| 09/09/2003 | US6617158 Contacting progenitor cells ex vivo with a cytokine (transforming growth factor); use for treating anemia and other blood disorders |
| 09/09/2003 | US6617157 Using inactivating agent of given formula to inactivate any virus contained in donor blood, blood products, or other biological compositions; can also use in vaccines |
| 09/09/2003 | US6617145 Enzymatic protein for use in treatment of thrombosis |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 09/09/2003 | US6617132 Nucleotide sequences which code polypeptide for use in treating osteoporosis, tumor metastasis, microbial infections, viral infection, sepsis, inflammation, vision defects, cachicia and muscle disorders |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/09/2003 | US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease |
| 09/09/2003 | US6617121 Snail, new tumoral progression marker and target protein of new antitumoral compounds |
| 09/09/2003 | US6617120 Nuclear receptor for use as tool in human therapeutics and diagnostics |
| 09/09/2003 | US6617117 MAP kinases: polypeptides, polynucleotides and uses thereof |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | US6617109 Contacting a biological sample from a patient with a probe of given nucleotide sequence; detecting amount of an expressed polynucleotide that hybridizes to the probe |
| 09/09/2003 | US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer |
| 09/09/2003 | US6617101 Lipophilic quenching of viral inactivating agents |
| 09/09/2003 | US6616941 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 09/09/2003 | US6616939 Lactose or glucose and a mineral supplement ensuring restoration of digestive losses; efficient quantity of soluble vegetable proteins and vegetable lipids ensuring suitable appropriate energy intake. |
| 09/09/2003 | US6616938 Method of making chewing gum containing colloidal bismuth subcitrate |
| 09/09/2003 | US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 09/09/2003 | US6616926 Methods of modulating lipid metabolism and storage |
| 09/09/2003 | US6616925 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 09/09/2003 | US6616914 Method for pulmonary and oral delivery of pharmaceuticals |
| 09/09/2003 | CA2244867C Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 09/09/2003 | CA2239498C Bioartificial devices and cellular matrices therefor |
| 09/09/2003 | CA2142121C Effects of actin filaments on fibrin clot structure and lysis |
| 09/09/2003 | CA2139937C Antioxidation food product, antioxidation preparation and antioxidation method |
| 09/09/2003 | CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation |
| 09/09/2003 | CA2101648C Polysaccharide-protein conjugates |
| 09/09/2003 | CA2062105C Purified mite allergen |
| 09/09/2003 | CA2057291C A stable pharmaceutical composition of human calcitonin |
| 09/09/2003 | CA2036770C Inhibitors of nitric oxide biosynthesis |
| 09/07/2003 | WO2003074701A1 p18AβrP GENE AND p18AβrP PROTEIN, NOVEL GENE/PROTEIN (p60TRP) INTERACTING THEREWITH TO INHIBIT CELL DEATH AND CELL DEATH PROMOTER |
| 09/07/2003 | CA2432937A1 P18abrp gene and p18abrp protein, and novel gene/protein (p60trp) suppressing cell death and substances promoting cell death by interaction with the same |
| 09/04/2003 | WO2003073351A2 Screening process |
| 09/04/2003 | WO2003073107A2 Neuropeptide receptor and uses thereof |
| 09/04/2003 | WO2003073104A2 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases |
| 09/04/2003 | WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 09/04/2003 | WO2003073097A2 Methods for isolating ligands e.g. t cell epitopes |
| 09/04/2003 | WO2003072800A2 Haemophilus adherence and penetration proteins |
| 09/04/2003 | WO2003072787A2 Method for detection of leptin receptor ligands |
| 09/04/2003 | WO2003072780A1 Novel proteins, dnas thereof and use of the same |
| 09/04/2003 | WO2003072779A1 Method of using pituitary-specific genes |
| 09/04/2003 | WO2003072771A2 Method of preparing a treatment product using a togaviridae expression construct |
| 09/04/2003 | WO2003072767A2 Regulation of human lipase |
| 09/04/2003 | WO2003072754A2 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 09/04/2003 | WO2003072749A2 Enkurin and uses thereof |
| 09/04/2003 | WO2003072745A2 Antigene locks and therapeutic uses thereof |
| 09/04/2003 | WO2003072741A2 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 09/04/2003 | WO2003072740A2 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | WO2003072738A2 Beta chain-associated regulator of apoptosis |
| 09/04/2003 | WO2003072737A2 Biological inhibitions induced by contact inhibitory factor |
| 09/04/2003 | WO2003072735A2 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 09/04/2003 | WO2003072731A2 STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS |
| 09/04/2003 | WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines |
| 09/04/2003 | WO2003072724A2 Human analogs of murine deubiquitinating protease genes |
| 09/04/2003 | WO2003072715A2 Gasp1: a follistatin domain containing protein |
| 09/04/2003 | WO2003072714A2 Follistatin domain containing proteins |
| 09/04/2003 | WO2003072713A2 Use of bcma as an immunoregulatory agent |
| 09/04/2003 | WO2003072712A2 A novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 09/04/2003 | WO2003072709A2 Variant tat proteins and methods for use thereof |
| 09/04/2003 | WO2003072705A2 Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina) |
| 09/04/2003 | WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/04/2003 | WO2003072609A1 Tick chitinase |
| 09/04/2003 | WO2003072608A1 Anti-human tenascin monoclonal antibody |
| 09/04/2003 | WO2003072606A2 Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use |
| 09/04/2003 | WO2003072604A1 Transmembrane nfat inhibitory peptide |
| 09/04/2003 | WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 09/04/2003 | WO2003072600A2 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53 |
| 09/04/2003 | WO2003072599A2 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 09/04/2003 | WO2003072598A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 09/04/2003 | WO2003072597A1 Intermediates and methods for making heptapeptide oxytocin analogues |
| 09/04/2003 | WO2003072595A2 Methods and products based on oligomerization of stress proteins |
| 09/04/2003 | WO2003072594A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 09/04/2003 | WO2003072593A2 Bone targeting peptides |
| 09/04/2003 | WO2003072591A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/04/2003 | WO2003072590A1 Rna interference mediated inhibition of map kinase genes |
| 09/04/2003 | WO2003072556A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | WO2003072543A2 Methods of preventing or treating brain ischemia or brain injury |
| 09/04/2003 | WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 09/04/2003 | WO2003072195A2 Method for administering glp-1 molecules |
| 09/04/2003 | WO2003072130A1 Oxygen carrier system, artificial oxygen carrier and reducing agent |
| 09/04/2003 | WO2003072129A1 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
| 09/04/2003 | WO2003072128A2 Methods and compositions for treating bone or cartilage defects |
| 09/04/2003 | WO2003072126A2 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 09/04/2003 | WO2003072124A1 Induction method for cell differentiation |
| 09/04/2003 | WO2003072123A1 Stabilized albumin preparaions |
| 09/04/2003 | WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
| 09/04/2003 | WO2003072072A1 Method of stimulation of melanin production and induction of skin tanning |
| 09/04/2003 | WO2003072061A2 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 09/04/2003 | WO2003072060A2 Polypeptide formulation |
| 09/04/2003 | WO2003072059A2 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| 09/04/2003 | WO2003072058A2 Dna-binding polyamide drug conjugates |
| 09/04/2003 | WO2003072050A2 Prevention of and therapy for radiation toxicity of normal tissues using drugs which block il-1 activity |
| 09/04/2003 | WO2003072040A2 Administration of agents for the treatment of inflammation |